Cargando…
DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway
BACKGROUND: Disabled homolog 2 interacting protein (DAB2IP) plays a tumor-suppressive role in several types of human cancers. However, the molecular status and function of the DAB2IP gene in esophageal squamous cell carcinoma (ESCC) patients who received definitive chemoradiotherapy is rarely report...
Autores principales: | Tong, Zhuting, Fang, Weiyang, Xu, Meng, Xia, YeYe, Wang, Rui, Li, Yue, Zha, Tianqi, Xiao, Liang, Pan, Shuhao, Chai, Huiping, Zhao, Lei, Wang, Hao, Pan, Huaguang, Chen, Xiangcun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897861/ https://www.ncbi.nlm.nih.gov/pubmed/35248066 http://dx.doi.org/10.1186/s12935-022-02535-9 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma
por: Zhu, Yumeng, et al.
Publicado: (2022) -
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour
por: Dote, H, et al.
Publicado: (2005) -
Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β
por: Shapira, Keren E., et al.
Publicado: (2014) -
Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer
por: Shen, Yi-Jun, et al.
Publicado: (2014)